DAVID SIDRANSKY

Profile

First Name

: DAVID

Middle Name

:

Last Name

: SIDRANSKY

Related Companies
Titles
Company Name
Related People
DIRECTOR
ALFACELL CORP
JOANNE BARSA, JOHN BRANCACCIO, JOHN P. BRANCACCIO, STEPHEN K. CARTER, DONALD R. CONKLIN, LAWRENCE A. KENYON, FRED KNOLL, CHARLES MUNIZ, PATRICK OSTRONIC, PATRICK OSTRONICK, KUSLIMA SHOGEN, DAVID SIDRANDKY, JAMIE SULLEY, JAMIE SULLY, PAUL WEISS, PAUL M. WEISS
DIRECTOR
KV PHARMACEUTICAL CO /DE/
ROBERT E. BALDINI, GREGORY S. BENTLEY, PATRICK J CHRISTMAS, GREGORY J DIVIS, GREGORY J. DIVIS, JR., MARK A. DOW, ERIC HARON, DAVID S. HERMELIN, JOSEPH D. LEHRER, JOE MCGINNIS, THOMAS S MCHUGH, THOMAS S. MCHUGH, STEVE NIELSON, JONATHAN SIEGEL, ANA I. STANCIC
DIRECTOR
ROSETTA GENOMICS LTD.
RANIT AHARONOV, TOMER ASSIS, ISAAC BENTWICH, KENNETH BERLIN, ODED BIRAN, AYELET CHAJUT, YOAV CHELOUCHE, GERALD DOGON, TINA EDMONSTON, KEREN GIVLI, TAMI FISHMAN JUTKOWITZ, TZIPORA SHOSHANI KUPITZ, MOSHE MANY, BRIAN MARKISON, BRIAN A MARKISON, JOSHUA ROSENSWEIG, RACHELI VIZMAN, TALI YARON-ELDAR
DIRECTOR
MORRIA BIOPHARMACEUTICALS PLC
ROB BAZEMORE, MELISSA BRADFORD-KLUG, DAVID BYRNE, MARK COHEN, YUVAL COHEN, WENDY DICICCO, ROBERT DOMAN, AMOS EIRAN, DOV ELEFANT, KAMEEL FARAG, PETER FELDSCHREIBER, ABIZER GASLIGHTWALA, MICHAEL GRISSINGER, ALAN HARRIS, WA-EL HASHAD, JAMES HILL, TORSTEN HOMBECK, HOYOUNG HUH, RACHELLE JACQUES, JOHNSON LAU, JIM NEAL, MILES NUNN, SAMIR PATEL, SANDIP PATEL, FREDRIC PRICE, DR. RAY PRUDO, RAY PRUDO, GILEAD RADAY, CLIVE RICHARDSON, GUR ROSHWALB, ALLAN SHAW, STUART UNGAR, DONALD WILLIAMS, SAUL YEDGAR
DIRECTOR
CHAMPIONS ONCOLOGY, INC.
JOEL ACKERMAN, DOUGLAS D. BURKETT, PH.D., ARTHUR EPKER, III, GARY GEMIGNANI, JAMES M. MARTELL, JAMES MCGORRY, DANIEL MENDELSON, DAVID MILLER, RONNIE MORRIS, RONNIE MORRIS, M.D., ABBA D. POLIAKOFF, ABBA DAVID POLIAKOFF, MARK R. SCHONAU, DAVID SIDRANKSKY, DAVID SIDRANSKY, M.D., ANA STANCIC, ANA I. STANCIC, SCOTT TOBIN
DIRECTOR
CELSUS THERAPEUTICS PLC.
ROB BAZEMORE, MELISSA BRADFORD-KLUG, DAVID BYRNE, MARK COHEN, YUVAL COHEN, WENDY DICICCO, ROBERT DOMAN, AMOS EIRAN, DOV ELEFANT, KAMEEL FARAG, PETER FELDSCHREIBER, ABIZER GASLIGHTWALA, MICHAEL GRISSINGER, ALAN HARRIS, WA-EL HASHAD, JAMES HILL, TORSTEN HOMBECK, HOYOUNG HUH, RACHELLE JACQUES, JOHNSON LAU, JIM NEAL, MILES NUNN, SAMIR PATEL, SANDIP PATEL, FREDRIC PRICE, DR. RAY PRUDO, RAY PRUDO, GILEAD RADAY, CLIVE RICHARDSON, GUR ROSHWALB, ALLAN SHAW, STUART UNGAR, DONALD WILLIAMS, SAUL YEDGAR
EXECUTIVE OFFICER, DIRECTOR
Y LABS, INC.
DIRECTOR
IMMUNE PHARMACEUTICALS INC
DANIEL KAZADO, ISAAC KOBRIN, RENE LERER, ANA STANCIC, DANIEL G. TEPER
DIRECTOR, EXECUTIVE OFFICER
ORGENESIS INC.
YARON ADLER, DENNIS BEDORET, HUGUES BULTOT, VERED CAPLAN, SAV DIPASQUALE, FERBER FERBER, SARAH FERBER, ETTI HANOCHI, DARREN HEAD, ELLIOT MALTZ, VICTOR MILLER, ASHISH NANDA, MARIO PHILIPS, NEIL REITHINGER, JOSEPH TENNE, DOV WEINERG, GUY YACHIN, YACHIN YACHIN
DIRECTOR
TAMIR BIOTECHNOLOGY, INC.
JOANNE BARSA, JOHN BRANCACCIO, JOHN P. BRANCACCIO, STEPHEN K. CARTER, DONALD R. CONKLIN, LAWRENCE A. KENYON, FRED KNOLL, CHARLES MUNIZ, PATRICK OSTRONIC, PATRICK OSTRONICK, KUSLIMA SHOGEN, DAVID SIDRANDKY, JAMIE SULLEY, JAMIE SULLY, PAUL WEISS, PAUL M. WEISS
DIRECTOR
GALMED PHARMACEUTICALS LTD.
ALLEN BAHARAFF, CAROL BROSGART, TALI GORFINE, LIAT HAYARDENY, CHAIM HURVITZ, WILLIAM MARTH, SHMUEL NIR, RAN OREN, YOHAI STENZLER, TALI YARON-ELDAR
EXECUTIVE OFFICER
ISRAEL BIOTECH FUND II, L.P.
YUVAL CABILLY, IDO ZAIRI
DIRECTOR
ADVAXIS, INC.
RONI APPEL, RONI A. APPEL, KEN A. BERLIN, KENNETH BERLIN, RICHARD BERMAN, VERED BISKER-LEIB, YUVAL CABILLY, FREDRICK COBB, IGOR GITELMAN, ROY GOLAN, MURRAY A. GOLDBERG, ANDRES GUTIERREZ, SAMIR KHLEIF, BRIDGET MARTELL, THOMAS MCKEARN, THOMAS L. MCKEARN, THOMAS MOORE, THOMAS A. MOORE, PINI ORBACH, JAMES PATTON, MARK J. ROSENBLUM, JOHN ROTHMAN, JOHN M. ROTHMAN, ROBERT SPIEGEL
DIRECTOR
AYALA PHARMACEUTICALS, INC.
RONI APPEL, RONI A. APPEL, KEN A. BERLIN, KENNETH BERLIN, RICHARD BERMAN, VERED BISKER-LEIB, YUVAL CABILLY, FREDRICK COBB, IGOR GITELMAN, ROY GOLAN, MURRAY A. GOLDBERG, ANDRES GUTIERREZ, SAMIR KHLEIF, BRIDGET MARTELL, THOMAS MCKEARN, THOMAS L. MCKEARN, THOMAS MOORE, THOMAS A. MOORE, PINI ORBACH, JAMES PATTON, MARK J. ROSENBLUM, JOHN ROTHMAN, JOHN M. ROTHMAN, ROBERT SPIEGEL
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-03-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NOT APPLICABLE 
Equity 
2024-03-03 
2023-11-02
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-10-18 
2023-09-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NOT APPLICABLE 
Equity 
2023-08-31 
2022-04-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-03-30 
2022-02-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2022-01-31 
2021-04-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
 
2021-04-14 
2020-01-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-01-21 
2019-07-24
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2019-07-09 
2018-02-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-01-26 
2018-01-25
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2018-01-11 
2017-08-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2017-08-09 
2016-12-30
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2016-05-12 
2016-05-20
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2016-05-12 
2015-12-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-12-10 
2015-09-10
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2015-09-04 
2015-03-25
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$5,000,001 - $25,000,000 
Equity 
2015-03-13 
2014-07-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-07-07 
2014-04-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-03-14 
2013-09-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2013-09-24 
2013-08-26
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2013-08-20 
2013-02-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$5,000,001 - $25,000,000 
Equity 
2013-01-28 
2013-02-01
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2013-01-18 
2012-12-13
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2012-11-30 
2012-02-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity, Debt 
2012-01-26 
2011-11-01
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2011-10-19 
2011-04-01
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2011-03-17 
2011-03-07
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2010-12-01 
2011-03-07
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2011-02-23 
2011-03-04
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-02-17 
2011-03-03
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2010-12-01 
2011-03-03
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2011-02-23 
2010-12-06
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2010-11-17 
2009-11-02
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2009-10-19